Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GLB1 | P16278 | 1/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16760810 | 0.94 | LMNA (0.32) | LMNACYP2C9GBA1GLAFUCA1 | |
| SCHEMBL15484213 | 0.83 | TSHR (0.44) | LMNAGBA1GLAGLB1FUCA1 | |
| SCHEMBL15484178 | 0.82 | TSHR (0.40) | TSHR | |
| SCHEMBL63815 | 0.80 | — | — | |
| SCHEMBL18905183 | 0.80 | — | — | |
| SCHEMBL15484132 | 0.79 | LMNA (0.45) | LMNACYP2C9TSHR | |
| SCHEMBL24268893 | 0.79 | GBA1 (0.39) | LMNACYP2C9GBA1GLAGLB1 | |
| SCHEMBL19228704 | 0.79 | GBA1 (0.39) | LMNACYP2C9GBA1GLAGLB1 | |
| SCHEMBL10038592 | 0.79 | GBA1 (0.39) | LMNACYP2C9GBA1GLAGLB1 | |
| SCHEMBL22196099 | 0.79 | GBA1 (0.39) | LMNACYP2C9GBA1GLAGLB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024034600-A1 | OIL-IN-WATER-TYPE EMULSION COMPOSITION | 花王株式会社 | 2024-02-15 | — | — | WO | disclosed |
| EP-2700705-B1 | LIQUID DETERGENT COMPOSITION | KAO CORP (JP) | 2018-12-19 | — | — | EP | disclosed |
| EP-2700636-B1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-9359324-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
| US-9051293-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| EP-2700705-A1 | LIQUID DETERGENT COMPOSITION | Kao Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | LMNA 3658/4885CYP2C9 86/4885GBA1 4164/4885 |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | LMNA 3658/4885CYP2C9 86/4885GBA1 4164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.